Naval G. Daver, MD | Authors

Articles

Combination Checkpoint Therapy Gains Ground in AML and MDS

November 09, 2017

Checkpoint-based immune therapies have revolutionized the therapy of solid tumors by achieving breakthrough improvements in melanoma, lung cancer, renal cancer, bladder cancers, and head and neck tumors, among others.